BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND MPL, TPOR, P40238, 4352, ENSG00000117400, CD110, MPLV, C-MPL, RP1-92O14_1
40830 results:

  • 1. Intelligent nanovesicle for remodeling tumor microenvironment and circulating tumor chemoimmunotherapy amplification.
    Huai M; Wang Y; Li J; Pan J; Sun F; Zhang F; Zhang Y; Xu L
    J Nanobiotechnology; 2024 May; 22(1):257. PubMed ID: 38755645
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Non-specific uptake of
    Li Y; Gao J; Li Y; Duan X; Shen C
    Sci Rep; 2024 May; 14(1):11141. PubMed ID: 38750103
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Assessing quality of hepato-pancreato-biliary surgery: nationwide benchmarking.
    de Graaff MR; Hendriks TE; Wouters M; Nielen M; de Hingh I; Koerkamp BG; van Santvoort HC; Busch OR; den Dulk M; Klaase JM; van Zwet E; Bonsing BA; Grünhagen DJ; Besselink MG; Kok NFM
    Br J Surg; 2024 May; 111(5):. PubMed ID: 38747683
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genetically determined gut microbiota associates with pulmonary arterial hypertension: a Mendelian randomization study.
    Yuan Y; Li S; Yan M; Yang Y; Zhong C; Hu Y
    BMC Pulm Med; 2024 May; 24(1):235. PubMed ID: 38745167
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance).
    Quintanilha JCF; Sibley AB; Liu Y; Niedzwiecki D; Halabi S; Rogers L; O'Neil B; Kindler H; Kelly W; Venook A; McLeod HL; Ratain MJ; Nixon AB; Innocenti F; Owzar K
    BMC Genomics; 2024 May; 25(1):473. PubMed ID: 38745123
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Impact on Long-term Survival of a Standardized Histopathological Protocol on the R1 Incidence in Pancreatoduodenectomy for pancreatic Ductal Adenocarcinoma.
    Moiş E; Graur F; Puia C; Vlad I; Moldovan S; Ursu CP; Nechita VI; Vălean D; Furcea L; Puia A; Zaharie F; Popa C; Bodea R; Iancu C; Rusu I; Hajjar NA
    Chirurgia (Bucur); 2024 Apr; 119(2):171-183. PubMed ID: 38743830
    [No Abstract]    [Full Text] [Related]  

  • 7. EMP1 correlated with cancer progression and immune characteristics in pan-cancer and ovarian cancer.
    Zhang J; Yang J; Li X; Mao L; Zhang Y; Liu Y; Bao Y
    Mol Genet Genomics; 2024 May; 299(1):51. PubMed ID: 38743077
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Multiple asynchronous recurrence as a predictive factor for refractoriness against locoregional and surgical therapy in patients with intermediate-stage hepatocellular carcinoma.
    Kasuga R; Taniki N; Chu PS; Tamura M; Tabuchi T; Yamaguchi A; Hayatsu S; Koizumi J; Ojiro K; Hoshi H; Kaneko F; Morikawa R; Noguchi F; Yamataka K; Usui S; Ebinuma H; Itano O; Hasegawa Y; Abe Y; Kitago M; Inoue M; Nakatsuka S; Jinzaki M; Kitagawa Y; Kanai T; Nakamoto N
    Sci Rep; 2024 May; 14(1):10896. PubMed ID: 38740983
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. MKLN1-AS promotes pancreatic cancer progression as a crucial downstream mediator of HIF-1α through miR-185-5p/TEAD1 pathway.
    Chen J; Li L; Feng Y; Zhao Y; Sun F; Zhou X; Yiqi D; Li Z; Kong F; Kong X
    Cell Biol Toxicol; 2024 May; 40(1):30. PubMed ID: 38740637
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Exploiting the ferroaddiction of pancreatic cancer cells using Fe-doped nanoparticles.
    Lomphithak T; Sae-Fung A; Sprio S; Tampieri A; Jitkaew S; Fadeel B
    Nanomedicine; 2024 Jan; 55():102714. PubMed ID: 38738528
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. pancreatic GHRHomas in Patients with or without Multiple Endocrine Neoplasia Type 1 (MEN 1) : An Analysis of 36 Reported Cases.
    Yamasaki R
    J Med Invest; 2024; 71(1.2):1-8. PubMed ID: 38735704
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Standard Nutritional Assessment Tools Are Unable to Predict Loss of Muscle Mass in Patients Due to Undergo pancreatico-Duodenectomy: Highlighting the Need for Detailed Nutritional Assessment.
    Phillips ME; Robertson MD; Bennett-Eastley K; Rowe L; Frampton AE; Hart KH
    Nutrients; 2024 Apr; 16(9):. PubMed ID: 38732516
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Strengthening the Evidence for a Causal Link between Type 2 Diabetes Mellitus and pancreatic cancer: Insights from Two-Sample and Multivariable Mendelian Randomization.
    Ke TM; Lophatananon A; Muir KR
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731833
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Enrichment and Evaluation of Antitumor Properties of Total Flavonoids from
    Yang S; Chu G; Wu J; Zhang G; Du L; Lin R
    Molecules; 2024 Apr; 29(9):. PubMed ID: 38731467
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The influence of delayed gastric emptying on quality of life after partial duodenopancreatectomy.
    Klein M; Warschkow R; Ukegjini K; Krstic D; Burri P; Chatziisaak D; Steffen T; Schmied B; Probst P; Tarantino I
    Langenbecks Arch Surg; 2024 May; 409(1):155. PubMed ID: 38727871
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Tumor Microenvironment Modulates Invadopodia Activity of Non-Selected and Acid-Selected pancreatic cancer Cells and Its Sensitivity to Gemcitabine and C18-Gemcitabine.
    Carvalho TMA; Audero MM; Greco MR; Ardone M; Maggi T; Mallamaci R; Rolando B; Arpicco S; Ruffinatti FA; Pla AF; Prevarskaya N; Koltai T; Reshkin SJ; Cardone RA
    Cells; 2024 Apr; 13(9):. PubMed ID: 38727266
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Exosomal PD-L1 in cancer and other fields: recent advances and perspectives.
    Lu MM; Yang Y
    Front Immunol; 2024; 15():1395332. PubMed ID: 38726017
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Genomic Profiling of Rare Undifferentiated Sarcomatoid Subtypes of pancreatic Carcinomas: In Search of Therapeutic Targets.
    Faber EB; Krause HB; Amin K; Walker P; Hosein PJ; Shields AF; Lenz HJ; Prakash A; Goel S; Oberley M; Malleo G; Luchini C; Hwang J; Florou V; Garrido-Laguna I; Lou E
    JCO Precis Oncol; 2024 May; 8():e2300595. PubMed ID: 38723231
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Rutinosides-derived from Sarocladium strictum 6-O-α-rhamnosyl-β-glucosidase show enhanced anti-tumoral activity in pancreatic cancer cells.
    Weiz G; González AL; Mansilla IS; Fernandez-Zapico ME; Molejón MI; Breccia JD
    Microb Cell Fact; 2024 May; 23(1):133. PubMed ID: 38720294
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Immune checkpoint inhibitor associated diarrhoea.
    Al-Hussainy A; Adams J; Simmons J; Kennedy J
    BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38719255
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2042.